Gaxos Health Expands Medical Advisory Board
Gaxos.ai Inc. (GXAI)
Company Research
Source: GlobeNewswire
Roseland, NJ, April 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has expanded its Medical Advisory Board with the appointment of Dr. Eric Margolis and Dr. Jeff Pavell. “The addition of top medical talent to our Medical Advisory Board reflects our continued commitment to pursuing a best-in-class solution for Gaxos Health,” said Vadim Mats, CEO of Gaxos.AI. “An advisory board of experts in their respective fields will allow to create a better product and advancing our mission of creating value for shareholders.” Dr. Eric Margolis, M.D. is a Board-Certified Urologic surgeon with over 25 years of experience in private practice in Northern New Jersey. He received his undergraduate degree from Cornell University, his MD degree from Upstate Medical school in Syracuse, N.Y. and completed his urology residency at The Mount Sinai Hospital in New York
Show less
Read more
Impact Snapshot
Event Time:
GXAI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GXAI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GXAI alerts
High impacting Gaxos.ai Inc. news events
Weekly update
A roundup of the hottest topics
GXAI
News
- Gaxos.ai Regains Compliance with Nasdaq Listing RequirementsGlobeNewswire
- Gaxos.ai Inc. Announces Closing of $3.5 Million Private Placement Priced At-The-Market under Nasdaq RulesGlobeNewswire
- Gaxos.ai Inc. Announces $3.5 Million Private Placement Priced At-The-Market under Nasdaq RulesGlobeNewswire
- Gaxos Acquires Rights to AI-enabled Technology from Top Biohacking AppGlobeNewswire
- Gaxos.ai Inc. Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 8, 2024GlobeNewswire
GXAI
Sec Filings
- 4/18/24 - Form 424B3
- 4/17/24 - Form EFFECT
- 4/4/24 - Form S-3
- GXAI's page on the SEC website